Browse by all authors Browse By Author ID - Peter Steer

Browse Results (10 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Gray, Peter H., Flenady, Vicki J., Charles, Bruce G., Steer, Peter A., on behalf of the Caffeine Collaborative Study Group, Shearman, A., Hegarty, J. and Rogers, Y. (2011) Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour. Journal of Paediatrics and Child Health, 47 4: 167-172. doi:10.1111/j.1440-1754.2010.01943.x 75   9 Cited 11 times in Scopus11 0
Charles, Bruce G., Townsend, Sarah R., Steer, Peter A., Flenady, Vicki J., Gray, Peter H. and Shearman, Andrew (2008) Caffeine citrate treatment for extremely premature infants with apnea: Population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Therapeutic Drug Monitoring, 30 6: 709-716. doi:10.1097/FTD.0b013e3181898b6f 144   20 Cited 26 times in Scopus26 0
Steer, Peter A. and Henderson-Smart, David J. (2000) Caffeine versus theophylline for apnea in preterm infants. Cochrane Database of Systematic Reviews, 2000 2: CD000273. 39   Cited 13 times in Scopus13
Henderson-Smart, David J. and Steer, Peter A. (2010) Caffeine versus theophylline for apnea in preterm infants. Cochrane Database of Systematic Reviews, 2010 1: CD000273-1-CD000273-20. doi:10.1002/14651858.CD000273.pub2 139   8 Cited 3 times in Scopus3 0
Henderson-Smart, David J and Steer, Peter A. (2000) Doxapram treatment for apnea in preterm infants [Intervention Review]. Cochrane Database of Systematic Reviews, 2000 2: CD000074. 64  
Steer, P., Flenady, V., Shearman, A., Charles, B. G., Gray, P. H., Henderson-Smart, D., Bury, G., Fraser, S., Hegarty, J., Rogers, Y., Reid, S., Horton, L., Charlton, M., Jacklin, R. and Walsh, A. (2004) High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Archives of Disease In Childhood, 89 Supp. 1: F499-F503. doi:10.1136/adc.2002.023432 108   24 Cited 38 times in Scopus38 0
Henderson-Smart, David J. and Steer, Peter A. (2008) Methylxanthine treatment for apnea in preterm infants [Intervention Review]. Cochrane Database of Systematic Reviews, 4: CD000140.1-CD000140.19. doi:10.1002/14651858.CD000140 12   8 Cited 0 times in Scopus0 0
Charles, B. G., Townsend, S., Lee, T. C., Steer, P., Gray, P., Flenady, V. J. and Shearman, A. D. (2003). Pharmacokinetics and absolute bioavailability of caffeine in extremely premature infants: A population modelling approach using sparse data. In: Integrating research into practice. Annual Conference of Australasian Pharmaceutical Sciences Association APSA 2003, Bondi Beach, NSW, (66-66). 3-5 December 2003. 129  
Lee, Toong Chow, Charles, Bruce, Steer, Peter, Flenady, Vicki and Shearman, Andrew (1997) Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity. Clinical Pharmacology and Therapeutics, 61 6: 628-640. doi:10.1016/S0009-9236(97)90097-7 57   38 Cited 46 times in Scopus46 1
Henderson-Smart, David J. and Steer, Peter A. (2000) Prophylactic methylxanthine for preventing of apnea in preterm infants. Cochrane Database of Systematic Reviews, 2000 2: CD000432. doi:10.1002/14651858.CD000432 50   3 Cited 0 times in Scopus0 0